In this interview, Bruce Levy, MD discusses the scientific basis of SPMs in respiratory health, emphasizing their role in lung inflammation resolution, particularly for asthma and RSV infections. He notes the impact of lipoxin deficiency on asthma severity and how supplementation with these mediators offers therapeutic potential, promoting tissue repair and reducing lung damage. Dr. Levy stresses the importance of dietary strategies in enhancing SPM functionality and overall respiratory health, underscoring the need for innovative therapeutic approaches to address severe viral pneumonia challenges.
Bruce Levy, MD, is Division Chief, Pulmonary & Critical Care Medicine at Brigham and Women’s Hospital. Dr. Levy is a Professor and the Chair of the Department of Medicine at Harvard Medical School.